{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:54:29Z","timestamp":1794030869585,"version":"4.8.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"International Myeloma Society Paula and Rodger Riney Foundation translational research award"},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41590-024-01808-x","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T10:01:56Z","timestamp":1712743316000},"page":"820-833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["An IL-1\u03b2-driven neutrophil\u2013stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-6154","authenticated-orcid":false,"given":"Madelon M. E.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathelijne","family":"Fokkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Papazian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Czeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein K.","family":"Appelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddie","family":"van Heusden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco M.","family":"Hoogenboezem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrin","family":"Tahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs A.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C.","family":"van de Woestijne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"B\u00fcttner-Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van Duin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"Broijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-2237","authenticated-orcid":false,"given":"Pieter","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1095-4273","authenticated-orcid":false,"given":"Tom","family":"Cupedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"1808_CR1","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos, C. I., Charles, K. A., McMillan, D. C. & Clarke, S. J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15, e493\u2013e503 (2014).","journal-title":"Lancet Oncol."},{"key":"1808_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"SK Kumar","year":"2017","unstructured":"Kumar, S. K. et al. Multiple myeloma. Nat. Rev. Dis. Prim. 3, 17046 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1808_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.12233","volume":"263","author":"Y Kawano","year":"2015","unstructured":"Kawano, Y. et al. Targeting the bone marrow microenvironment in multiple myeloma. Immunol. Rev. 263, 160\u2013172 (2015).","journal-title":"Immunol. Rev."},{"key":"1808_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41590-021-00931-3","volume":"22","author":"MME de Jong","year":"2021","unstructured":"de Jong, M. M. E. et al. The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape. Nat. Immunol. 22, 769\u2013780 (2021).","journal-title":"Nat. Immunol."},{"key":"1808_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2016.08.002","volume":"31","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. The CXCL8\u2013CXCR1\/2 pathways in cancer. Cytokine Growth Factor Rev. 31, 61\u201371 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1808_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/rheumatology\/keu035","volume":"53","author":"HL Wright","year":"2014","unstructured":"Wright, H. L., Cross, A. L., Edwards, S. W. & Moots, R. J. Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo. Rheumatology 53, 1321\u20131331 (2014).","journal-title":"Rheumatology"},{"key":"1808_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26460-z","volume":"12","author":"Z Zheng","year":"2021","unstructured":"Zheng, Z. et al. Lung mesenchymal stromal cells influenced by TH2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3. Nat. Commun. 12, 6202 (2021).","journal-title":"Nat. Commun."},{"key":"1808_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","volume":"16","author":"ME Shaul","year":"2019","unstructured":"Shaul, M. E. & Fridlender, Z. G. Tumour-associated neutrophils in patients with cancer. Nat. Rev. Clin. Oncol. 16, 601\u2013620 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1808_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick, C. C. & Malanchi, I. Neutrophils in cancer: heterogeneous and multifaceted. Nat. Rev. Immunol. 22, 173\u2013187 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1808_CR10","doi-asserted-by":"publisher","first-page":"e98259","DOI":"10.1371\/journal.pone.0098259","volume":"9","author":"M Shen","year":"2014","unstructured":"Shen, M. et al. Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS ONE 9, e98259 (2014).","journal-title":"PLoS ONE"},{"key":"1808_CR11","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst. 106, dju124 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"1808_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","volume":"522","author":"SB Coffelt","year":"2015","unstructured":"Coffelt, S. B. et al. IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345\u2013348 (2015).","journal-title":"Nature"},{"key":"1808_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv, J. Y. et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 10, 562\u2013573 (2015).","journal-title":"Cell Rep."},{"key":"1808_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2567.2008.02950.x","volume":"125","author":"RC Furze","year":"2008","unstructured":"Furze, R. C. & Rankin, S. M. Neutrophil mobilization and clearance in the bone marrow. Immunology 125, 281\u2013288 (2008).","journal-title":"Immunology"},{"key":"1808_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2308511120","volume":"120","author":"R Sender","year":"2023","unstructured":"Sender, R. et al. The total mass, number, and distribution of immune cells in the human body. Proc. Natl Acad. Sci. USA 120, e2308511120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1808_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fonc.2014.00348","volume":"4","author":"C Botta","year":"2014","unstructured":"Botta, C., Gull\u00e0, A., Correale, P., Tagliaferri, P. & Tassone, P. Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities. Front. Oncol. 4, 348 (2014).","journal-title":"Front. Oncol."},{"key":"1808_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood.2019004537","volume":"136","author":"C Perez","year":"2020","unstructured":"Perez, C. et al. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma. Blood 136, 199\u2013209 (2020).","journal-title":"Blood"},{"key":"1808_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58859-x","volume":"10","author":"A Romano","year":"2020","unstructured":"Romano, A. et al. High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling. Sci. Rep. 10, 1983 (2020).","journal-title":"Sci. Rep."},{"key":"1808_CR19","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s00277-020-04092-5","volume":"99","author":"A Szudy-Szczyrek","year":"2020","unstructured":"Szudy-Szczyrek, A. et al. Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen. Ann. Hematol. 99, 2881\u20132891 (2020).","journal-title":"Ann. Hematol."},{"key":"1808_CR20","doi-asserted-by":"publisher","first-page":"18792","DOI":"10.18632\/oncotarget.13320","volume":"8","author":"L Shi","year":"2017","unstructured":"Shi, L. et al. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget 8, 18792\u201318801 (2017).","journal-title":"Oncotarget"},{"key":"1808_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41419-019-1959-5","volume":"10","author":"C Giallongo","year":"2019","unstructured":"Giallongo, C. et al. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma. Cell Death Dis. 10, 704 (2019).","journal-title":"Cell Death Dis."},{"key":"1808_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30755-0","volume":"13","author":"D Dimitrov","year":"2022","unstructured":"Dimitrov, D. et al. Comparison of methods and resources for cell\u2013cell communication inference from single-cell RNA-seq data. Nat. Commun. 13, 3224 (2022).","journal-title":"Nat. Commun."},{"key":"1808_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1172\/JCI19930","volume":"113","author":"SH Jia","year":"2004","unstructured":"Jia, S. H. et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J. Clin. Invest. 113, 1318\u20131327 (2004).","journal-title":"J. Clin. Invest"},{"key":"1808_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.exphem.2013.02.008","volume":"41","author":"SU Venkateshaiah","year":"2013","unstructured":"Venkateshaiah, S. U. et al. NAMPT\/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity. Exp. Hematol. 41, 547\u2013557 (2013).","journal-title":"Exp. Hematol."},{"key":"1808_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12055-2","volume":"10","author":"A Manag\u00f2","year":"2019","unstructured":"Manag\u00f2, A. et al. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation. Nat. Commun. 10, 4116 (2019).","journal-title":"Nat. Commun."},{"key":"1808_CR26","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1038\/bcj.2015.3","volume":"5","author":"PJ Hengeveld","year":"2015","unstructured":"Hengeveld, P. J. & Kersten, M. J. B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy? Blood Cancer J. 5, e282 (2015).","journal-title":"Blood Cancer J."},{"key":"1808_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","volume":"18","author":"C Bossen","year":"2006","unstructured":"Bossen, C. & Schneider, P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18, 263\u2013275 (2006).","journal-title":"Semin. Immunol."},{"key":"1808_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","volume":"34","author":"N Shah","year":"2020","unstructured":"Shah, N., Chari, A., Scott, E., Mezzi, K. & Usmani, S. Z. B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. Leukemia 34, 985\u20131005 (2020).","journal-title":"Leukemia"},{"key":"1808_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","volume":"11","author":"SA Hamarsheh","year":"2020","unstructured":"Hamarsheh, S. A. & Zeiser, R. NLRP3 inflammasome activation in cancer: a double-edged sword. Front. Immunol. 11, 1444 (2020).","journal-title":"Front. Immunol."},{"key":"1808_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang, Y., Wang, H., Kouadir, M., Song, H. & Shi, F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 10, 128 (2019).","journal-title":"Cell Death Dis."},{"key":"1808_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4065\/84.2.114","volume":"84","author":"JA Lust","year":"2009","unstructured":"Lust, J. A. et al. Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1\u03b2-induced interleukin 6 production and the myeloma proliferative component. Mayo Clin. Proc. 84, 114\u2013122 (2009).","journal-title":"Mayo Clin. Proc."},{"key":"1808_CR32","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","volume":"54","author":"D Hofbauer","year":"2021","unstructured":"Hofbauer, D. et al. \u03b22-Microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity 54, 1772\u20131787 (2021).","journal-title":"Immunity"},{"key":"1808_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10555-018-9752-y","volume":"37","author":"D Tong","year":"2018","unstructured":"Tong, D. et al. The roles of the COX2\/PGE2\/EP axis in therapeutic resistance. Cancer Metastasis Rev. 37, 355\u2013368 (2018).","journal-title":"Cancer Metastasis Rev."},{"key":"1808_CR34","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1182\/blood-2006-11-010389","volume":"108","author":"M Munder","year":"2006","unstructured":"Munder, M. et al. Suppression of T-cell functions by human granulocyte arginase. Blood 108, 1627\u20131634 (2006).","journal-title":"Blood"},{"key":"1808_CR35","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.leukres.2012.03.012","volume":"36","author":"M Fragioudaki","year":"2012","unstructured":"Fragioudaki, M. et al. Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma. Leuk. Res. 36, 1004\u20131008 (2012).","journal-title":"Leuk. Res."},{"key":"1808_CR36","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","volume":"103","author":"JRM Moreaux","year":"2004","unstructured":"Moreaux, J. R. M. et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103, 3148\u20133157 (2004).","journal-title":"Blood"},{"key":"1808_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature14242","volume":"518","author":"K Busch","year":"2015","unstructured":"Busch, K. et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 518, 542\u2013546 (2015).","journal-title":"Nature"},{"key":"1808_CR38","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1634\/stemcells.2006-0589","volume":"25","author":"A Sch\u00e4ffler","year":"2007","unstructured":"Sch\u00e4ffler, A. & B\u00fcchler, C. Adipose tissue-derived stromal cells\u2014basic and clinical implications for novel cell-based therapies. Stem Cells 25, 818\u2013827 (2007).","journal-title":"Stem Cells"},{"key":"1808_CR39","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13, 1235\u20131242 (2006).","journal-title":"Chem. Biol."},{"key":"1808_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Fri\u0161\u010di\u0107","year":"2021","unstructured":"Fri\u0161\u010di\u0107, J. et al. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54, 1002\u20131021 (2021).","journal-title":"Immunity"},{"key":"1808_CR41","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.18632\/oncotarget.3510","volume":"6","author":"MI Molejon","year":"2015","unstructured":"Molejon, M. I. et al. Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma. Oncotarget 6, 7408\u20137423 (2015).","journal-title":"Oncotarget"},{"key":"1808_CR42","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1038\/s41388-019-0899-y","volume":"38","author":"C Yang","year":"2019","unstructured":"Yang, C. et al. Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas. Oncogene 38, 7113\u20137132 (2019).","journal-title":"Oncogene"},{"key":"1808_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5054-6","volume":"18","author":"W Owattanapanich","year":"2018","unstructured":"Owattanapanich, W., Suphadirekkul, K., Kunacheewa, C., Ungprasert, P. & Prayongratana, K. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis. BMC Cancer 18, 1126 (2018).","journal-title":"BMC Cancer"},{"key":"1808_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.leukres.2013.05.014","volume":"37","author":"D Lemancewicz","year":"2013","unstructured":"Lemancewicz, D. et al. Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features. Leuk. Res. 37, 1089\u20131093 (2013).","journal-title":"Leuk. Res."},{"key":"1808_CR45","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2016.217","volume":"36","author":"PF Yu","year":"2017","unstructured":"Yu, P. F. et al. TNF\u03b1-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene 36, 482\u2013490 (2017).","journal-title":"Oncogene"},{"key":"1808_CR46","doi-asserted-by":"publisher","first-page":"16471","DOI":"10.18632\/oncotarget.4106","volume":"6","author":"M Gr\u00e9goire","year":"2015","unstructured":"Gr\u00e9goire, M. et al. Neutrophils trigger a NF-\u03baB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas. Oncotarget 6, 16471\u201316487 (2015).","journal-title":"Oncotarget"},{"key":"1808_CR47","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41591-021-01520-5","volume":"27","author":"M Friedrich","year":"2021","unstructured":"Friedrich, M. et al. IL-1-driven stromal\u2013neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nat. Med. 27, 1970\u20131981 (2021).","journal-title":"Nat. Med."},{"key":"1808_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou, S. et al. Targeting STAT3 in cancer immunotherapy. Mol. Cancer 19, 145 (2020).","journal-title":"Mol. Cancer"},{"key":"1808_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/cancers11050731","volume":"11","author":"PSY Chong","year":"2019","unstructured":"Chong, P. S. Y., Chng, W. J. & de Mel, S. STAT3: a promising therapeutic target in multiple myeloma. Cancers 11, 731 (2019).","journal-title":"Cancers"},{"key":"1808_CR50","doi-asserted-by":"publisher","first-page":"e0265958","DOI":"10.1371\/journal.pone.0265958","volume":"17","author":"S-K Heo","year":"2022","unstructured":"Heo, S.-K. et al. Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling. PLoS ONE 17, e0265958 (2022).","journal-title":"PLoS ONE"},{"key":"1808_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-018-0108-8","volume":"4","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells. Cell Death Discov. 4, 44 (2018).","journal-title":"Cell Death Discov."},{"key":"1808_CR52","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1158\/0008-5472.CAN-06-0190","volume":"66","author":"Y-T Tai","year":"2006","unstructured":"Tai, Y.-T. et al. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res. 66, 6675\u20136682 (2006).","journal-title":"Cancer Res."},{"key":"1808_CR53","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1158\/1078-0432.CCR-07-0753","volume":"13","author":"P Neri","year":"2007","unstructured":"Neri, P. et al. Neutralizing B-cell-activating factor antibody improves survival and inhibits osteoclastogenesis in a severe combined immunodeficient human multiple myeloma model. Clin. Cancer Res. 13, 5903\u20135909 (2007).","journal-title":"Clin. Cancer Res."},{"key":"1808_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-022-00340-x","volume":"8","author":"W Pilcher","year":"2023","unstructured":"Pilcher, W. et al. Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma. NPJ Genom. Med. 8, 3 (2023).","journal-title":"NPJ Genom. Med."},{"key":"1808_CR55","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","volume":"106","author":"JRM Moreaux","year":"2005","unstructured":"Moreaux, J. R. M. et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106, 1021\u20131030 (2005).","journal-title":"Blood"},{"key":"1808_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cyto.2012.06.317","volume":"60","author":"G Xu","year":"2012","unstructured":"Xu, G. et al. BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells. Cytokine 60, 505\u2013513 (2012).","journal-title":"Cytokine"},{"key":"1808_CR57","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1182\/blood-2014-02-554071","volume":"123","author":"C Hope","year":"2014","unstructured":"Hope, C. et al. TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood 123, 3305\u20133315 (2014).","journal-title":"Blood"},{"key":"1808_CR58","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1046\/j.1365-2141.1998.01101.x","volume":"103","author":"V Costes","year":"1998","unstructured":"Costes, V. et al. Interleukin-1 in multiple myeloma: producer cells and their role in the control of IL-6 production. Br. J. Haematol. 103, 1152\u20131160 (1998).","journal-title":"Br. J. Haematol."},{"key":"1808_CR59","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2141.2012.09141.x","volume":"158","author":"AJ Vangsted","year":"2012","unstructured":"Vangsted, A. J. et al. A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma. Br. J. Haematol. 158, 515\u2013518 (2012).","journal-title":"Br. J. Haematol."},{"key":"1808_CR60","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"1808_CR61","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"1808_CR62","doi-asserted-by":"publisher","DOI":"10.1140\/epjb\/e2013-40829-0","volume":"86","author":"L Waltman","year":"2013","unstructured":"Waltman, L. & van Eck, N. J. A smart local moving algorithm for large-scale modularity-based community detection. Eur. Phys. J. B 86, 471 (2013).","journal-title":"Eur. Phys. J. B"},{"key":"1808_CR63","doi-asserted-by":"publisher","first-page":"861","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","journal-title":"J. Open Source Softw."},{"key":"1808_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496\u2013502 (2019).","journal-title":"Nature"},{"key":"1808_CR65","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/cei.13205","volume":"194","author":"WC Cheng","year":"2018","unstructured":"Cheng, W. C., Saleh, F., Abuaisha Karim, B., Hughes, F. J. & Taams, L. S. Comparative analysis of immune cell subsets in peripheral blood from patients with periodontal disease and healthy controls. Clin. Exp. Immunol. 194, 380\u2013390 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"1808_CR66","unstructured":"Kolde, R. Pheatmap: pretty heatmaps. R package version 1 (2012)."},{"key":"1808_CR67","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"1808_CR68","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1808_CR69","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1093\/bioinformatics\/btaa1011","volume":"36","author":"DG Bunis","year":"2020","unstructured":"Bunis, D. G., Andrews, J., Fragiadakis, G. K., Burt, T. D. & Sirota, M. dittoSeq: universal user-friendly single-cell and bulk RNA sequencing visualization toolkit. Bioinformatics 36, 5535\u20135536 (2020).","journal-title":"Bioinformatics"},{"key":"1808_CR70","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.4077","volume":"13","author":"D T\u00fcrei","year":"2016","unstructured":"T\u00fcrei, D., Korcsm\u00e1ros, T. & Saez-Rodriguez, J. OmniPath: guidelines and gateway for literature-curated signaling pathway resources. Nat. Methods 13, 966\u2013967 (2016).","journal-title":"Nat. Methods"},{"key":"1808_CR71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"1808_CR72","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).","journal-title":"F1000Res"},{"key":"1808_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1808_CR74","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"1808_CR75","unstructured":"Blighe, K., Rana, S. & Lewis, M. EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. R package version 1 (2019)."},{"key":"1808_CR76","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis, 2nd edn (Springer-Verlag, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"1808_CR77","doi-asserted-by":"publisher","unstructured":"de Jong, M. M. E. & Cupedo, T. A stromal cell-neutrophil axis promotes tumor-supportive bone marrow inflammation in newly diagnosed and treated myeloma. Mendeley Data https:\/\/doi.org\/10.17632\/sm7fvt8hsg.2 (2023).","DOI":"10.17632\/sm7fvt8hsg.2"},{"key":"1808_CR78","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BGM Durie","year":"2006","unstructured":"Durie, B. G. M. et al. International uniform response criteria for multiple myeloma. Leukemia 20, 1467\u20131473 (2006).","journal-title":"Leukemia"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01808-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01808-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T17:06:14Z","timestamp":1714669574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-024-01808-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1808"],"URL":"https:\/\/doi.org\/10.1038\/s41590-024-01808-x","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B.-H. has received speaker\u2019s fees from Sanofi and Pfizer and workshop sponsoring from Novartis. F.G. has received honoraria from Amgen, Celgene, Janssen, Takeda, BMS, AbbVie and GlaxoSmithKline and is on advisory boards for Roche, Adaptive Biotechnologies, Oncopeptides, bluebird bio and Pfizer. P.M. is on advisory boards for and has received honoraria from Janssen. A.B. is on advisory boards for and has received honoraria from Janssen, Sanofi, Amgen and BMS. P.S. has received research funding from Karyopharm, Janssen, Amgen, Celgene and BMS and is on the advisory board for Pfizer. T.C. has received research support from Janssen. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}